Chemical chaperone therapy for GM1-gangliosidosis

Cellular and Molecular Life Sciences : CMLS
Yoshiyuki Suzuki

Abstract

We have proposed a chemical chaperone therapy for lysosomal diseases, based on a paradoxical phenomenon that an exogenous competitive inhibitor of low molecular weight stabilizes the target mutant molecule and restores its catalytic activity as a molecular chaperone intracellularly. After Fabry disease experiments, we investigated a new synthetic chaperone compound N-octyl-4-epi-beta-valienamine (NOEV) in a GM1-gangliosidosis model mice. Orally administered NOEV entered the brain through the blood-brain barrier, enhanced beta-galactosidase activity, reduced the substrate storage, and clinically improved neurological deterioration. We hope that chemical chaperone therapy will prove useful for some patients with GM1-gangliosidosis and potentially other lysosomal storage diseases with central nervous system involvement.

Citations

Feb 18, 2010·Journal of Inherited Metabolic Disease·Raphael Schiffmann
Mar 19, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Caterina PortoGiancarlo Parenti
Dec 9, 2010·Orphanet Journal of Rare Diseases·Giuseppina AndreottiMaria Vittoria Cubellis
Sep 13, 2013·Future Medicinal Chemistry·Katsumi HigakiEiji Nanba
Jul 5, 2011·Trends in Neurosciences·Mark L SchultzBeverly L Davidson
May 28, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Tamar ShacharAnthony H Futerman
Mar 31, 2016·Brain Research·Mark L SchultzAndrew P Lieberman
Jan 1, 2012·ISRN Biochemistry·Thomas Kolter
May 16, 2017·Advanced Drug Delivery Reviews·Melani Solomon, Silvia Muro
Apr 17, 2021·The Application of Clinical Genetics·Allisandra K RhaDouglas R Martin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Journal of Inherited Metabolic Disease
Yoshiyuki Suzuki
Proceedings of the National Academy of Sciences of the United States of America
Junichiro MatsudaYoshiyuki Suzuki
© 2021 Meta ULC. All rights reserved